Trial intelligence / Profile preview

Curcumin-mediated photodynamic therapy vs topical corticosteroid for oral lichen planus

IRCT20221016056202N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin in oral lichen planus (OLP) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Nov 2022; status: completed.

02

Drugs

curcumin
03

Conditions

oral lichen planus (OLP)

Beyond the preview

Go deeper on IRCT20221016056202N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221016056202N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call